Director · Faeth Therapeutics, Inc. · Faeth Therapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
25.0K
Price
—
Executed
Sep 11, 2026
Disclosed
Sep 15, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Sep 11 executedSep 15, 2026 disclosed
FTH · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Faeth Therapeutics, Inc. — Stock Option (right to buy)
Ticker
FTH
Shares
25.0K
Price per share
$0
Execution date (reported)
Sep 11, 2026
Owned after transaction
25.0K shares
Days from execution to publication
4
What this establishes
Vousden Karen H filed this Form 4 reporting a grant or award of FTH on Sep 11, 2026. It became public on Sep 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Vousden Karen Hcik:0001723884
Issuer
Faeth Therapeutics, Inc.cik:0001829802
Revision history · 0
No field has changed since this record was first ingested.
